hero image
Dr. Diego  Delgado - University Health Network. Toronto, ON, CA

Dr. Diego Delgado Dr. Diego  Delgado

Cardiologist | University Health Network

Toronto, ON, CANADA

Dr. Delgado is Associate Professor in the Division of Cardiology and Cardiac Transplantation at the University Health Network.





loading image


Understanding Amyloidosis.Peter Munk Cardiac Centre DR. DIEGO DELGADO, PROFESOR UNIVERSIDAD ESTATAL DE CUENCA




Dr Diego Delgado graduated in Medicine from the Universidad del Salvador in Buenos Aires, Argentina. He completed his Internal Medicine and Cardiology training in Hospital Espanol in Buenos Aires. Subsequently he completed a research fellowship in cardiac transplantation at Rush Presbyterian St Luke’s Medical Center in Chicago, US. He completed a research/clinical fellowship in heart failure and transplantation at the Toronto General Hospital.

Dr. Delgado completed his Maters of Science in Clinical Epidemiology at the University of Toronto and the Leadership Develpment Program at Rotman School of Management in Toronto.

Dr. Delgado holds the Reuben and Florence Fenwick Family Chair in the Medical Management of Heart Failure. Dr. Delgado is a transplant cardiologist, member of the Heart Failure, Transplantation and Mechanical Assist Device Program at University Health Network.

Currently, Dr Delgado is Associate Professor in the Division of Cardiology and Cardiac Transplantation at the University Health Network. Dr Delgado is the Medical Director of the Inpatient Cardiology Service in the Division of Cardiology at the Toronto General Hospital. He is also de Site Director for the Division of Cardiology.

Dr. Delgado is the President of the Interamerican Society of Cardiology and past Chair of the Canadian Cardiac Transplant Group.

He is the author of more than 100 publications in the area of heart failure, transplantation and mechanical assist devices. His interests are immunologic aspects of heart failure and transplantation and cardio oncology.

Industry Expertise (2)


Medical/Dental Practice

Areas of Expertise (4)



Heart Failure

Heart Transplantation

Education (3)

University of Toronto, Rotman School of Management: Certification, Leadership Development Program 2013

University of Toronto: M.S., Clinical Epidemiology 2008

Universidad del Salvador: M.D., Medicine 1994

Media Appearances (2)

For many doctors, stethoscope is still state-of-the-heart technology

Toronto Star  


The stethoscope slung over Dr. Diego Delgado’s chest is very close to his heart.

“I’m wearing my father’s,” says Delgado, 45, a cardiologist at Toronto’s University Health Network...

view more

Take care of your heart, especially in the winter

Toronto Star  


January is especially busy for many cardiologists because heart attacks peak around this time of year. We eat and drink more over the holidays, the cold weather hits and our habits change. This can be a dangerous combination of factors for people with pre-existing heart conditions or who have cardiac risk factors. These can include being overweight or obese, having high cholesterol, being inactive or smoking...

view more

Articles (5)

New Developments in HLA-G in Cardiac Transplantation Human Immunology


Human Leukocyte Antigen-G (HLA-G) is a non-classical class 1b protein, whose gene is located on chromosome 6 (6p21. 31). HLA-G inhibits the immune cells' cytotoxic activity by interacting with specific receptors on their membranes. Since it is a naturally ...

view more

A randomized feasibility trial of clonidine to reduce perioperative cardiac risk in patients on chronic beta-blockade: the EPIC study Canadian Journal of Anesthesia


Clonidine may help prevent cardiac complications in patients undergoing non-cardiac surgery and receiving chronic beta-blocker therapy. We conducted a multicentre pilot randomized trial to estimate recruitment rates for a full-scale trial and to assess the safety and tolerability of combining clonidine with chronic beta-blockade...

view more

Autologous stem cell transplant is an effective therapy for carefully selected patients with AL amyloidosis: experience of a single institution British Journal of Haematology


Autologous stem-cell transplant has been widely used to treat patients with AL amyloidosis. However, transplant-related mortality rates are high, and a recent randomized trial suggested that non-transplant regimens produced comparable results with less ...

view more

Clinical differences between continuous flow ventricular assist devices: a comparison between HeartMate II and HeartWare HVAD Journal of Cardiac Surgery


The HeartWare ventricular assist device (HVAD) is a new generation centrifugal flow VAD recently introduced in Canada. The objective of this study was to compare the HVAD device to the HeartMate II (HMII) axial flow device. Very few studies have compared ...

view more

Cost-effectiveness of ventricular assist device therapy as a bridge to transplant in comparison to non-bridged cardiac recipients Circulation


Current available treatment options for advanced heart failure include heart transplantation (HTx) and ventricular assist device (VAD) therapy. This project aimed to evaluate the cost-effectiveness of bridge to transplant (BTT)-VAD relative to direct HTx in ...

view more